Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction
Authors:
- Natalia V. BogatchevaNBNatalia V. Bogatcheva
- Djanybek AdyshevDADjanybek Adyshev
- Bolot MambetsarievBMBolot Mambetsariev
- Nurgul MoldobaevaNMNurgul Moldobaeva
- Alexander D. VerinAVAlexander D. Verin
- 1 February 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 292 (2) , L487-L499
Abstract
2-Methoxyestradiol (2ME), a promising anti-tumor agent, is currently tested in phase I/II clinical trial to assess drug tolerance and clinical effects. 2ME is known to affect microtubule (MT) polymerization rather than act through estrogen receptors. We hypothesized that 2ME, similar to other MT inhibitors, disrupts endothelial barrier properties. We show that 2ME decreases transendothelial electrical resistance and increases FITC-dextran leakage across human pulmonary artery endothelial monolayer, which correlates with 2ME-induced MT depolymerization. Pretreatment of endothelium with MT stabilizer taxol significantly attenuates the decrease in transendothelial resistance. 2ME treatment results in the induction of F-actin stress fibers, accompanied by the increase in myosin light chain (MLC) phosphorylation. The experiments with Rho kinase (ROCK) and MLC kinase inhibitors and ROCK small interfering RNA (siRNA) revealed that increase in MLC phosphorylation is attributed to the ROCK activation rather than MLC kinase activation. 2ME induces significant ERK1/2, p38, and JNK phosphorylation and activation; however, only p38 activation is relevant to the 2ME-induced endothelial hyperpermeability. p38 activation is accompanied by a marked increase in MAPKAP2 and 27-kDa heat shock protein (HSP27) phosphorylation level. Taxol significantly decreases p38 phosphorylation and activation in response to 2ME stimulation. Vice versa, p38 inhibitor SB203580 attenuates MT rearrangement in 2ME-challenged cells. Together, these results indicate that 2ME-induced barrier disruption is governed by MT depolymerization and p38- and ROCK-dependent mechanisms. The fact that certain concentrations of 2ME induce endothelial hyperpermeability suggests that the issue of the maximum-tolerated dose of 2ME for cancer treatment should be addressed with caution.Keywords
This publication has 28 references indexed in Scilit:
- Caldesmon is a cytoskeletal target for PKC in endotheliumJournal of Cellular Biochemistry, 2006
- Involvement of microtubules and Rho pathway in TGF‐β1‐induced lung vascular barrier dysfunctionJournal of Cellular Physiology, 2005
- ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundlesJournal of Cell Biology, 2005
- Standing up to the challenge of standing: a siphon does not support cerebral blood flow in humansAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Cardiovascular Pharmacology of Estradiol MetabolitesThe Journal of Pharmacology and Experimental Therapeutics, 2004
- A Simple Quantitative Method for Evaluation of Angiogenesis ActivityASSAY and Drug Development Technologies, 2004
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cellsOncogene, 1999
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and Hela cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1989